Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.
about
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods.Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease.Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality.Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.
P2860
Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antibody-free quantification o ...... ng targeted mass spectrometry.
@ast
Antibody-free quantification o ...... ng targeted mass spectrometry.
@en
type
label
Antibody-free quantification o ...... ng targeted mass spectrometry.
@ast
Antibody-free quantification o ...... ng targeted mass spectrometry.
@en
prefLabel
Antibody-free quantification o ...... ng targeted mass spectrometry.
@ast
Antibody-free quantification o ...... ng targeted mass spectrometry.
@en
P2093
P2860
P356
P1476
Antibody-free quantification o ...... ing targeted mass spectrometry
@en
P2093
Jérôme Vialaret
Nicolas Barthelemy
Pauline Bros
Sylvain Lehmann
Vincent Delatour
P2860
P356
10.3389/FNINS.2015.00302
P577
2015-09-01T00:00:00Z